Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, random

scientific article published in June 2005

Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, random is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1034789356
P356DOI10.1038/SJ.JHH.1001812
P698PubMed publication ID15647778
P5875ResearchGate publication ID8083186

P50authorCoenraad Dirk Adriaan StehouwerQ68596151
Casper G. SchalkwijkQ76998834
P2093author name stringJ W R Twisk
M T Schram
R G Ijzerman
F J van Ittersum
R A J M van Dijk
A Spoelstra-de Man
P2860cites workEffects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study InvestigatorsQ28144781
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetesQ28188162
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetesQ28188182
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>Q28204197
Longitudinal data analysis for discrete and continuous outcomesQ29547235
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathyQ29615215
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in womenQ29616306
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study GroupQ29617736
Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trialsQ33897188
Effects of antihypertensive drugs on vascular remodeling: do they predict outcome in response to antihypertensive therapy?Q34331686
Effect of losartan in aging-related endothelial impairmentQ43897720
Effects of eprosartan versus hydrochlorothiazide on markers of vascular oxidation and inflammation and blood pressure (renin-angiotensin system antagonists, oxidation, and inflammation).Q43919591
Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of deathQ43935480
Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1.Q44083504
Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).Q44242786
The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertensionQ44611131
Left ventricular mass increases with deteriorating glucose tolerance, especially in women: independence of increased arterial stiffness or decreased flow-mediated dilation: the Hoorn studyQ44745068
Endothelium-dependent and -independent vasodilation of large arteries in normoalbuminuric insulin-dependent diabetes mellitus.Q50985397
Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.Q51570195
von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic SubjectsQ57830297
Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with microalbuminuriaQ74631559
Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammationQ74651672
P433issue6
P921main subjectendotheliumQ111140
hydrochlorothiazideQ423930
P304page(s)429-437
P577publication date2005-06-01
P1433published inJournal of Human HypertensionQ15746469
P1476titleAggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, random
P478volume19